$201.3 Million
IGM Biosciences, Inc.
Initial Public Offering
Active Bookrunner
$60.7 Million
Bicycle Therapeutics Limited
Initial Public Offering
Active Bookrunner
$82.5 Million
Milestone Pharmaceuticals Inc.
Initial Public Offering
Active Bookrunner
$165.6 Million
Pliant Therapeutics, Inc.
Initial Public Offering
Active Bookrunner
$604.4 Million
Moderna Therapeutics, Inc.
Initial Public Offering
Passive Bookrunner
$120.0 Million
Arvinas
Initial Public Offering
Active Bookrunner
$117.3 Million
Crinetics Pharmaceuticals, Inc.
Initial Public Offering
Active Bookrunner
$138.0 Million
OptiNose AS
Initial Public Offering
Active Bookrunner
$136.9 Million
Menlo Therapeutics Inc.
Initial Public Offering
Active Bookrunner
$107.5 Million
Neuronetics, Inc.
Initial Public Offering
Active Bookrunner
Subscribe to United States

© 2025 Piper Sandler Companies. Since 1895. All rights reserved.